Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai - PubMed (original) (raw)
Affiliations
- PMID: 12223424
Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai
Qi Dai et al. Cancer Epidemiol Biomarkers Prev. 2002 Sep.
Abstract
Although the majority of ecological and experimental studies have suggested a potential role of phytoestrogens in breast cancer prevention, findings from epidemiological studies have been inconsistent. Part of the inconsistencies may be attributable to the difficulty in measuring intake levels of phytoestrogens. Overnight urine samples from 250 incident breast cancer cases and their individually matched controls were analyzed for urinary excretion rates of isoflavonoids, mammalian lignans, and citrus flavonoids. The study subjects were a subset of the participants in the Shanghai Breast Cancer Study, a large population-based case-control study conducted in Shanghai from 1996-1998. To minimize potential influence of treatment on the exposure of interest, urine samples from breast cancer cases were collected before cancer therapy. Urinary excretion of total isoflavonoids and mammalian lignans was substantially lower in breast cancer cases than in controls. The median excretion rate of total isoflavonoids was 13.97 nmol/mg creatinine in cases and 23.09 in controls (P = 0.01), and the median excretion rate of total lignans was 1.77 in cases and 4.16 in controls (P < 0.01). The risk of breast cancer was reduced with increasing excretion of total isoflavonoids (P for trend, 0.04) and total lignans (P for trend, <0.01), with adjusted odds ratios of 0.62 (95% confidence interval, 0.39-0.99) and 0.40 (95% confidence interval, 0.24-0.64) observed for the highest versus the lowest tertile of total isoflavonoid and lignan excretion, respectively. The adjusted odds ratio was 0.28 (95% confidence interval, 0.15-0.50) for women who had a high excretion rate of both total lignans and isoflavonoids compared with those with a low excretion of both groups of phytoestrogens. No association was observed with citrus flavonoids. The results from this study suggest that high intake of certain phytoestrogens may reduce the risk of breast cancer.
Similar articles
- Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
Dai Q, Franke AA, Yu H, Shu XO, Jin F, Hebert JR, Custer LJ, Gao YT, Zheng W. Dai Q, et al. Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):497-502. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12814993 Clinical Trial. - Urinary phytoestrogens and postmenopausal breast cancer risk.
den Tonkelaar I, Keinan-Boker L, Veer PV, Arts CJ, Adlercreutz H, Thijssen JH, Peeters PH. den Tonkelaar I, et al. Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):223-8. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11303591 - Urinary excretion of isoflavonoids and the risk of breast cancer.
Zheng W, Dai Q, Custer LJ, Shu XO, Wen WQ, Jin F, Franke AA. Zheng W, et al. Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):35-40. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 9950237 - Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know.
Velentzis LS, Woodside JV, Cantwell MM, Leathem AJ, Keshtgar MR. Velentzis LS, et al. Eur J Cancer. 2008 Sep;44(13):1799-806. doi: 10.1016/j.ejca.2008.05.019. Epub 2008 Jul 7. Eur J Cancer. 2008. PMID: 18614351 Review. - Phytoestrogens and breast cancer risk. Review of the epidemiological evidence.
Peeters PH, Keinan-Boker L, van der Schouw YT, Grobbee DE. Peeters PH, et al. Breast Cancer Res Treat. 2003 Jan;77(2):171-83. doi: 10.1023/a:1021381101632. Breast Cancer Res Treat. 2003. PMID: 12602916 Review.
Cited by
- Urinary sex steroid excretion levels during a soy intervention among young girls: a pilot study.
Maskarinec G, Morimoto Y, Novotny R, Nordt FJ, Stanczyk FZ, Franke AA. Maskarinec G, et al. Nutr Cancer. 2005;52(1):22-8. doi: 10.1207/s15327914nc5201_3. Nutr Cancer. 2005. PMID: 16091000 Free PMC article. - Equol production changes over time in pre-menopausal women.
Franke AA, Lai JF, Pagano I, Morimoto Y, Maskarinec G. Franke AA, et al. Br J Nutr. 2012 Apr;107(8):1201-6. doi: 10.1017/S0007114511004223. Epub 2011 Sep 16. Br J Nutr. 2012. PMID: 21920062 Free PMC article. Clinical Trial. - Epidemiological Evidences on Dietary Flavonoids and Breast Cancer Risk: A Narrative Review.
Sak K. Sak K. Asian Pac J Cancer Prev. 2017 Sep 27;18(9):2309-2328. doi: 10.22034/APJCP.2017.18.9.2309. Asian Pac J Cancer Prev. 2017. PMID: 28950673 Free PMC article. - Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype.
Hong KW, Ko KP, Ahn Y, Kim CS, Park SJ, Park JK, Kim SS, Kim Y. Hong KW, et al. Genes Nutr. 2012 Oct;7(4):567-74. doi: 10.1007/s12263-012-0292-8. Epub 2012 Apr 3. Genes Nutr. 2012. PMID: 22477055 Free PMC article. - Optimization of Culture Conditions for Fermentation of Soymilk Using Lactobacillus casei by Response Surface Methodology.
Khoshayand F, Goodarzi S, Shahverdi AR, Khoshayand MR. Khoshayand F, et al. Probiotics Antimicrob Proteins. 2011 Dec;3(3-4):159-67. doi: 10.1007/s12602-011-9079-2. Probiotics Antimicrob Proteins. 2011. PMID: 26781676
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical